172 terminated. 172 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 172 | Terminated 172 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase Levofloxacin, Placebo - Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Terminated | Gadjah Mada University | 49 | 2026-01-01 | 2026-10-01 |
| Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors Suvorexant Tablets, Placebo Control - Breast Cancer, Insomnia | Phase 4 | Terminated | Medical University of South Carolina | 6 | 2024-09-20 | 2026-08-12 |
| Ketamine-assisted Therapy for Advanced GI Cancer Ketamine, Ketamine Injectable Product, Meaning and Purpose therapy - Pancreatic Ductal Adenocarcinoma, Pain, Acute | Phase 4 | Terminated | Brian Anderson, MD | 1 | 2024-05-17 | 2025-05-21 |
| Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation Indocyanine green, SPY Portable Handheld Imaging - Parathyroid Dysfunction, Adenoma | Phase 4 | Terminated | University of Alabama at Birmingham | 417 | 2024-04-11 | 2026-05-06 |
| Contributions to Hypertension With Androgen Deprivation Therapy Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer | Phase 4 | Terminated | University of Colorado, Denver | 10 | 2023-09-20 | 2026-09-02 |
| Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors Hydroxyurea - Polycythemia Vera | Phase 4 | Terminated | Novartis Pharmaceuticals | 76 | 2023-07-28 | 2026-08-18 |
| Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients Acetaminophen and Ibuprofen, Normal saline - Delirium, Aged | Phase 4 | Terminated | Korea University Guro Hospital | 25 | 2023-06-15 | 2025-09-05 |
| Impact of Topical Tranexamic Acid in Breast Reconstruction Tranexamic Acid, Saline - Breast Cancer | Phase 4 | Terminated | University of California, San Francisco | 23 | 2023-04-20 | 2025-09-29 |
| Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy Bevacizumab, Atezolizumab, Sofosbuvir - Liver Cancer | Phase 4 | Terminated | M.D. Anderson Cancer Center | 2 | 2023-03-17 | 2024-12-31 |
| Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC Aliya Pulsed Electric Fields (PEF) ablation, Nivolumab plus Platinum Doublet Chemotherapy, Standard of care neoadjuvant therapy - NSCLC | Phase 4 | Terminated | Galvanize Therapeutics, Inc. | 5 | 2023-02-01 | 2024-07-19 |
| Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation Ceftolozane / Tazobactam Injection - Pneumonia, Hematologic Malignancy | Phase 4 | Terminated | Weill Medical College of Cornell University | 17 | 2023-01-10 | 2026-01-21 |
| Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas Propranolol three times a day, Propranolol twice a day, Timolol - Infantile Hemangioma | Phase 4 | Terminated | The University of Texas Health Science Center, Houston | 52 | 2022-06-23 | 2026-03-13 |
| RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery Remimazolam Besylate, Propofol, Midazolam - Sedation, ICU | Phase 4 | Terminated | Nanfang Hospital, Southern Medical University | 117 | 2022-03-16 | 2026-07-02 |
| The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer. Indocyanine green - Gastric Cancer | Phase 4 | Terminated | Copenhagen University Hospital, Rigshospitalet | 11 | 2022-03-11 | 2024-05-02 |
| Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer Biospecimen Collection, Letrozole, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 4 | Terminated | University of Washington | 62 | 2022-01-23 | 2026-06-04 |
| COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 Spikevax, Comirnaty, Spikevax bivalent Original/Omicron BA.1 - Cancer | Phase 4 | Terminated | Jules Bordet Institute | 152 | 2021-12-01 | 2024-01-17 |
| Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL Flumatinib, Imatinib - Acute Leukemia | Phase 4 | Terminated | Institute of Hematology & Blood Diseases Hospital, China | 39 | 2021-09-16 | 2025-05-01 |
| Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) Blinatumomab, Current Wearable Heatlth Monitoring System (CWHMS) - B-precursor Acute Lymphoblastic Leukemia | Phase 4 | Terminated | Amgen | 10 | 2021-08-26 | 2025-05-18 |
| Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases Gadoxetate disodium, Gadobenate dimeglumine - Oligometastatic Disease, Liver Metastases | Phase 4 | Terminated | University of Colorado, Denver | 10 | 2021-06-22 | 2026-09-25 |
| Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts Ribociclib - Breast Cancer | Phase 4 | Terminated | Georgetown University | 21 | 2021-05-20 | 2024-11-26 |
Showing 20 of 172. Sign in to see all of them.
Breast Neoplasms (18) · Prostatic Neoplasms (13) · Neoplasm Metastasis (10) · Carcinoma, Non-Small-Cell Lung (9) · Colorectal Neoplasms (9) · Lung Neoplasms (8) · Polycystic Ovary Syndrome (7) · Leiomyoma (6) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (5) · Carcinoma, Renal Cell (4) · Leukemia (4) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4) · Ovarian Neoplasms (4) · Pancreatic Neoplasms (4)
Neoplasms by Site (103) · Neoplasms by Histologic Type (54) · Pathological Conditions, Signs and Symptoms (44) · Urogenital Diseases (36) · Skin and Connective Tissue Diseases (33) · Digestive System Diseases (30) · Pathologic Processes (30) · Hemic and Lymphatic Diseases (29) · Skin Diseases (29) · Genital Diseases (28) · Digestive System Neoplasms (26) · Urogenital Neoplasms (26) · Female Urogenital Diseases (25) · Female Urogenital Diseases and Pregnancy Complications (25)
Dexamethasone (5) · Letrozole (5) · Saline Solution (5) · Sodium Chloride (5) · Bevacizumab (4) · Goserelin (4) · Leuprolide (4) · Capecitabine (3) · Cyclophosphamide (3) · Docetaxel (3) · Gemcitabine (3) · Ketamine (3) · Metformin (3) · Paclitaxel (3) · Pemetrexed (3)
M.D. Anderson Cancer Center (6) · Novartis Pharmaceuticals (6) · Hoffmann-La Roche (5) · Columbia University (3) · Mayo Clinic (3) · Merck Sharp & Dohme LLC (3) · Northwestern University (3) · University of Texas Southwestern Medical Center (3) · AstraZeneca (2) · CSA Medical, Inc. (2) · Clinigen, Inc. (2) · Hospices Civils de Lyon (2) · Indiana University (2) · Massachusetts General Hospital (2) · Peking University First Hospital (2)
United States (85) · China (12) · France (11) · Germany (10) · Spain (9) · Belgium (5) · Canada (5) · Netherlands (5) · South Korea (5) · Austria (4) · Italy (4) · Russia (4) · United Kingdom (4) · Denmark (3) · Czechia (2)
Jinming Yu, Ph.D, M.D (2) · Sherri Sheinfeld Gorin, PhD (2) · Aaron A Cohen, MD, MSc (1) · Abebe Haregewoin, MD, PhD (1) · Aleena Banerji, MD (1) · Alex Tessnow, MD (1) · Alexander Payatakes, M.D. (1) · Alexandra Geusau, Prof. Dr. (1) · Alice Shapiro, PhD (1)
PMID 32632956, PMID 38979716, PMID 18172212, PMID 18647805, PMID 21123449, PMID 21336429, PMID 21606131, PMID 21733508, PMID 22056077, PMID 22296075, PMID 22341881, PMID 24814583, PMID 25003376, PMID 25135035, PMID 25442036, PMID 28497402, PMID 30040817, PMID 30053905, PMID 30140912, PMID 30208456, PMID 30352714, PMID 30802304, PMID 31643128, PMID 32444264, PMID 32572189, PMID 33041718, PMID 33347618, PMID 35048355, PMID 35235189, PMID 36053283, PMID 36239858, PMID 36413252, PMID 37201751, PMID 37807952, PMID 38007586, PMID 38412408, PMID 38484432, PMID 39019875, PMID 39164407
2004 (2), 2018 (2), 2014 (1), 2019 (1), P01CA128115 (1), P30CA015704 (1), P30CA046934 (1), R01HL075079 (1)